The two countries already are working together behind the scenes. Michael Pillsbury, a senior fellow at the Hudson Institute who advises the Trump administration on China, pointed to efforts underway by the American biotechnology companies Inovio Pharmaceuticals, GeoVax and Gilead Sciences to develop a coronavirus treatment in China, some in partnership with Chinese companies.